Foster Market Research

Global Sleep Testing Services Market, By Test Type (Home Sleep Testing and In-lab Sleep Testing (Electroencephalogram, Full Polysomnography, CPAP/BiPAP Titration, Multiple Sleep Latency Test (MSLT), and Maintenance of Wakefulness Test (MWT)), By Application (Obstructive Sleep Apnea, Restless Legs Syndrome, Insomnia, Circadian Rhythm Sleeping Disorders, Rapid Eye Movement (REM) Sleep Disorder, and Narcolepsy), By End User (Hospitals, Sleep Centers, and Home Care Settings), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - Global Forecast, 2020-2025.

Published on : May 26, 2019

The global sleep testing services market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Sleep testing is pharmaceutical test used to acknowledge and detect sleeping disorders. This test reports oxygen level in blood, and breathing, brain signals, and heart beat rate. Sleep testing service is used to discover various disorders such as baffling chronic insomnia, rapid eye movement (REM), sleep apnea, narcolepsy, sleep behavior disorder, regular legs movement disorder, and others. Some of the drivers of the sleep testing services market are rising… Read more

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - Global Forecast, 2020-2025.

Published on : June 3, 2019

The global sarcoma biopsy market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Sarcoma is basically known as cancer of soft tissue whereas; biopsy is a process of withdrawing of a minor amount of tissue for observation under a microscope. Imaging tests may recommend the detection of sarcoma, but biopsy is executed to validate the diagnosis and to discover the type of sarcoma. Several kinds of biopsies are being conducted to detect sarcomas and most of the biopsies are needle biopsies, in which needle is used to retrieve the skeptical tissue of… Read more

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP), antinuclear antibody (ANA), uric acid and other tests), monitoring RA treatment efficiency tests (salicylate level count, muscle enzyme tests (CPK, Aldolase) and creatinine test), By End User (Diagnostics laboratories, Ambulatory surgical centers, Hospitals), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - Global Forecast, 2020-2025.

Published on : Sept. 14, 2019

The global rheumatoid arthritis diagnostic tests market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Rheumatoid arthritis (RA) is an autoimmune disease which impacts body’s own immune system by attacking its joint tissues, which leads to swelling of joint lining. Such swelling of joint lining results in unbearable pain, stiffness, soreness, burning, and redness. This disorder has no enduring cure and it lasts for long term. The chronic nature of rheumatoid arthritis has played a vital role in lavishing the growth of the global rheumatoi… Read more

Global PARP Inhibitor Biomarkers Market, By Product and Service Type (Product Type, (Kits, Assays), Service Type, (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, Others), By Application (Breast Cancer, Ovarian Cancer, Others (Prostate, Pancreatic, etc), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - Global Forecast, 2020-2025.

Published on : Oct. 5, 2019

The global PARP inhibitor biomarkers market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). PARP are poly (adenosine diphosphate [ADP] ribose) polymerase. It is a bunch of 17 enzymes that integrate various (poly) components of ADP ribose in a trammel and transmit them to the proteins. Poly (ADP-ribose) polymerase (PARP) inhibitor performs a major role in the overhaul of single-strand DNA. The double-strand DNA breaks would generally be restored by the procedure of homologous recombination restoration (HRR), which is a tricky procedure and contai… Read more

North America Outbound Medical Tourism Services Market, By Treatment Type (Cardiovascular Treatment, Cosmetic Surgery Treatment, Dental Treatment, Weight Loss Treatment, Spinal Surgery Treatment, Orthopedic Treatment, Neurological Treatment, Cancer Treatment, Fertility Treatment, and Others), By Application (Diagnostic Applications, Therapeutic Applications), By Country (U.S. and Canada). - Global Forecast, 2020-2025.

Published on : June 27, 2019

The North America outbound medical tourism services market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Medical tourism is explained as traveling of patients to several destinations for aspiring medical treatment. Medical tourism can be divided into three types namely, inbound medical tourism, intra bound medical tourism, and outbound medical tourism. Outbound medical tourism is explained as traveling of patients outside their country to get assistance of several medical treatments Read more

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Instruments and Reagents and Kits ), By Test Type (Immunodiagnostics, Molecular Diagnostics), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - Global Forecast, 2020-2025.

Published on : June 29, 2019

The global methicillin resistant staphylococcus aureus (MRSA) testing systems market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Methicillin resistant staphylococcus aureus (MRSA) testing is used to discover MRSAs. MRSA is a group of gram-positive bacteria which are genetically different from other strains of staphylococcus aureus and are more prone in hospitals and ambulatory surgical units where major surgeries are performed.

Industry Title